CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 4 Open-market sale Director sold 25,000 shares at $4.64 ($116,000)
- 4/A Grant or award Director acquired 50,000 shares (grant or award)
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Other events
- CT ORDER Other Confidential Order
- SC 13D Stake Beneficial Ownership Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change
- 10-K Report Annual Report
Page 16 of 50 · 983 filings